CLPT logo

ClearPoint Neuro (CLPT) Free Cash Flow

CLPT Annual FCF

-$14.77 M
+$2.54 M+14.68%

31 December 2023

CLPT Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLPT Quarterly FCF

-$1.21 M
+$1.46 M+54.61%

30 September 2024

CLPT Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLPT TTM FCF

-$9.08 M
+$820.00 K+8.29%

30 September 2024

CLPT TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLPT Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.7%+40.4%+45.8%
3 y3 years-78.2%+64.6%+22.5%
5 y5 years-214.7%-24.3%-201.5%

CLPT Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-14.8%+14.7%at high+79.2%at high+52.7%
5 y5-year-390.7%+14.7%-159.8%+79.2%-201.5%+52.7%
alltimeall time-390.7%+14.7%-159.8%+79.2%-380.6%+52.7%

ClearPoint Neuro Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
-$1.21 M(-54.6%)
-$9.08 M(-8.3%)
June 2024
-
-$2.67 M(-30.5%)
-$9.90 M(-22.6%)
Mar 2024
-
-$3.84 M(+183.0%)
-$12.79 M(-13.4%)
Dec 2023
-$14.77 M(-14.7%)
-$1.36 M(-33.2%)
-$14.77 M(-11.7%)
Sept 2023
-
-$2.03 M(-63.5%)
-$16.73 M(-12.8%)
June 2023
-
-$5.57 M(-4.3%)
-$19.18 M(+2.7%)
Mar 2023
-
-$5.82 M(+75.3%)
-$18.68 M(+7.9%)
Dec 2022
-$17.31 M(+34.6%)
-$3.32 M(-26.0%)
-$17.31 M(-1.5%)
Sept 2022
-
-$4.48 M(-11.4%)
-$17.58 M(+6.4%)
June 2022
-
-$5.06 M(+13.5%)
-$16.52 M(+9.1%)
Mar 2022
-
-$4.45 M(+24.1%)
-$15.15 M(+17.7%)
Dec 2021
-$12.87 M(+55.2%)
-$3.59 M(+4.9%)
-$12.87 M(+9.8%)
Sept 2021
-
-$3.42 M(-7.1%)
-$11.72 M(+21.3%)
June 2021
-
-$3.68 M(+69.6%)
-$9.66 M(+25.7%)
Mar 2021
-
-$2.17 M(-11.1%)
-$7.69 M(-7.3%)
Dec 2020
-$8.29 M(+175.4%)
-$2.44 M(+78.6%)
-$8.29 M(+31.3%)
Sept 2020
-
-$1.37 M(-20.0%)
-$6.31 M(+6.6%)
June 2020
-
-$1.71 M(-38.4%)
-$5.92 M(+14.5%)
Mar 2020
-
-$2.77 M(+494.7%)
-$5.17 M(+71.8%)
Dec 2019
-$3.01 M(-35.9%)
-$466.10 K(-52.2%)
-$3.01 M(-3.7%)
Sept 2019
-
-$974.30 K(+1.5%)
-$3.13 M(-0.4%)
June 2019
-
-$960.10 K(+57.5%)
-$3.14 M(-5.5%)
Mar 2019
-
-$609.50 K(+4.5%)
-$3.32 M(-29.2%)
Dec 2018
-$4.69 M
-$583.20 K(-40.9%)
-$4.69 M(-19.9%)
Sept 2018
-
-$986.40 K(-13.7%)
-$5.86 M(-10.9%)
June 2018
-
-$1.14 M(-42.3%)
-$6.58 M(-1.2%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$1.98 M(+13.3%)
-$6.65 M(+10.6%)
Dec 2017
-$6.02 M(+1.7%)
-$1.75 M(+2.7%)
-$6.02 M(+11.8%)
Sept 2017
-
-$1.70 M(+39.3%)
-$5.38 M(+5.6%)
June 2017
-
-$1.22 M(-9.2%)
-$5.10 M(-8.7%)
Mar 2017
-
-$1.35 M(+21.0%)
-$5.58 M(-5.7%)
Dec 2016
-$5.92 M(-32.1%)
-$1.11 M(-21.4%)
-$5.92 M(-3.4%)
Sept 2016
-
-$1.42 M(-17.0%)
-$6.13 M(-3.9%)
June 2016
-
-$1.71 M(+1.2%)
-$6.38 M(-16.0%)
Mar 2016
-
-$1.69 M(+27.5%)
-$7.60 M(-12.8%)
Dec 2015
-$8.71 M(+19.4%)
-$1.32 M(-20.7%)
-$8.71 M(-7.5%)
Sept 2015
-
-$1.67 M(-42.9%)
-$9.42 M(-5.2%)
June 2015
-
-$2.92 M(+4.0%)
-$9.94 M(+13.7%)
Mar 2015
-
-$2.81 M(+38.2%)
-$8.74 M(+19.8%)
Dec 2014
-$7.30 M(-8.2%)
-$2.03 M(-6.9%)
-$7.30 M(+7.6%)
Sept 2014
-
-$2.18 M(+26.5%)
-$6.78 M(+3.5%)
June 2014
-
-$1.73 M(+26.7%)
-$6.55 M(-7.2%)
Mar 2014
-
-$1.36 M(-10.1%)
-$7.06 M(-11.2%)
Dec 2013
-$7.95 M(+5.2%)
-$1.51 M(-22.4%)
-$7.95 M(-8.6%)
Sept 2013
-
-$1.95 M(-12.6%)
-$8.70 M(-0.1%)
June 2013
-
-$2.23 M(-0.8%)
-$8.71 M(+9.9%)
Mar 2013
-
-$2.25 M(-0.5%)
-$7.92 M(+4.8%)
Dec 2012
-$7.56 M(+20.7%)
-$2.26 M(+15.2%)
-$7.56 M(+42.7%)
Sept 2012
-
-$1.96 M(+35.5%)
-$5.30 M(+58.8%)
June 2012
-
-$1.45 M(-23.3%)
-$3.34 M(+76.7%)
Mar 2012
-
-$1.89 M
-$1.89 M
Dec 2011
-$6.27 M(-19.3%)
-
-
Dec 2010
-$7.77 M
-
-

FAQ

  • What is ClearPoint Neuro annual free cash flow?
  • What is the all time high annual FCF for ClearPoint Neuro?
  • What is ClearPoint Neuro annual FCF year-on-year change?
  • What is ClearPoint Neuro quarterly free cash flow?
  • What is the all time high quarterly FCF for ClearPoint Neuro?
  • What is ClearPoint Neuro quarterly FCF year-on-year change?
  • What is ClearPoint Neuro TTM free cash flow?
  • What is the all time high TTM FCF for ClearPoint Neuro?
  • What is ClearPoint Neuro TTM FCF year-on-year change?

What is ClearPoint Neuro annual free cash flow?

The current annual FCF of CLPT is -$14.77 M

What is the all time high annual FCF for ClearPoint Neuro?

ClearPoint Neuro all-time high annual free cash flow is -$3.01 M

What is ClearPoint Neuro annual FCF year-on-year change?

Over the past year, CLPT annual free cash flow has changed by +$2.54 M (+14.68%)

What is ClearPoint Neuro quarterly free cash flow?

The current quarterly FCF of CLPT is -$1.21 M

What is the all time high quarterly FCF for ClearPoint Neuro?

ClearPoint Neuro all-time high quarterly free cash flow is -$466.10 K

What is ClearPoint Neuro quarterly FCF year-on-year change?

Over the past year, CLPT quarterly free cash flow has changed by +$820.00 K (+40.37%)

What is ClearPoint Neuro TTM free cash flow?

The current TTM FCF of CLPT is -$9.08 M

What is the all time high TTM FCF for ClearPoint Neuro?

ClearPoint Neuro all-time high TTM free cash flow is -$1.89 M

What is ClearPoint Neuro TTM FCF year-on-year change?

Over the past year, CLPT TTM free cash flow has changed by +$7.66 M (+45.76%)